BT7401
/ Bicycle Therap, Cancer Research UK
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
January 07, 2020
Bicycle Therapeutics and Cancer Research UK to collaborate on development of new bicycle immuno-oncology candidate, BT7401
(Businesswire)
- “Bicycle Therapeutics plc…announced a second collaboration with Cancer Research UK, the world’s largest independent funder of cancer research, in which Cancer Research UK will fund and sponsor development of BT7401, a multivalent Bicycle CD137 agonist, through a Phase IIa clinical study.”
Licensing / partnership
January 07, 2020
Newly added product
(Businesswire)
- Preclinical, Oncology
Pipeline update
1 to 2
Of
2
Go to page
1